Nexalin Technology Highlights Positive Anxiety and Insomnia Data at NYC Neuromodulation Conference 2026
HOUSTON, Texas, June 16, 2026 Nexalin Technology announced that two clinical abstracts evaluating its proprietary Deep Intracranial Frequency Stimulation...
